LFMD Stock Overview
Operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 2/6 |
Past Performance | 0/6 |
Financial Health | 2/6 |
Dividends | 0/6 |
Rewards
Risk Analysis
LifeMD, Inc. Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | US$5.45 |
52 Week High | US$12.88 |
52 Week Low | US$3.46 |
Beta | 1.24 |
11 Month Change | -22.48% |
3 Month Change | -30.48% |
1 Year Change | 51.81% |
33 Year Change | -30.22% |
5 Year Change | 739.11% |
Change since IPO | 45.33% |
Recent News & Updates
It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks
Aug 16LifeMD: High Growth GLP-1 Telehealth Play At A Discount
Jul 31LifeMD: Pairing GLP-1 Agonists With Virtual Healthcare
Jun 11Recent updates
It's Down 27% But LifeMD, Inc. (NASDAQ:LFMD) Could Be Riskier Than It Looks
Aug 16LifeMD: High Growth GLP-1 Telehealth Play At A Discount
Jul 31LifeMD: Pairing GLP-1 Agonists With Virtual Healthcare
Jun 11LifeMD: Moving Towards Profitability
May 22Is LifeMD (NASDAQ:LFMD) Using Debt Sensibly?
Apr 25Even With A 29% Surge, Cautious Investors Are Not Rewarding LifeMD, Inc.'s (NASDAQ:LFMD) Performance Completely
Mar 30LifeMD: Results And Guidance Point To Continued Strength In Weight Management Program
Mar 13LifeMD's 2024: Striking A Balance Between Rapid Expansion And Sustainability
Jan 22LifeMD: A GLP-1 Play With A Kicker
Jan 11Is LifeMD, Inc. (NASDAQ:LFMD) Potentially Undervalued?
Jan 05Take Care Before Jumping Onto LifeMD, Inc. (NASDAQ:LFMD) Even Though It's 34% Cheaper
Jan 05Does This Valuation Of LifeMD, Inc. (NASDAQ:LFMD) Imply Investors Are Overpaying?
Dec 03Investors Still Aren't Entirely Convinced By LifeMD, Inc.'s (NASDAQ:LFMD) Revenues Despite 38% Price Jump
Apr 17Analysts Are Betting On LifeMD, Inc. (NASDAQ:LFMD) With A Big Upgrade This Week
Nov 17LifeMD launches at-home screening kits for breast, colon cancers
Sep 14LifeMD Non-GAAP EPS of -$0.22 beats by $0.01, revenue of $30.5M misses by $1.45M
Aug 11LifeMD CEO Justin Schreiber - Disrupting Healthcare With Telemedicine
Jan 10LifeMD: 4 Reasons You Should Avoid This Stock
Sep 29LifeMD: Telehealth Growth Spectacular
Sep 17Shareholder Returns
LFMD | US Healthcare Services | US Market | |
---|---|---|---|
7D | 4.6% | 4.9% | 1.6% |
1Y | 51.8% | -1.7% | 26.3% |
Return vs Industry: LFMD exceeded the US Healthcare Services industry which returned -1.7% over the past year.
Return vs Market: LFMD exceeded the US Market which returned 26.3% over the past year.
Price Volatility
LFMD volatility | |
---|---|
LFMD Average Weekly Movement | 9.9% |
Healthcare Services Industry Average Movement | 9.4% |
Market Average Movement | 6.4% |
10% most volatile stocks in US Market | 15.2% |
10% least volatile stocks in US Market | 3.2% |
Stable Share Price: LFMD's share price has been volatile over the past 3 months.
Volatility Over Time: LFMD's weekly volatility (10%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 209 | Justin Schreiber | lifemd.com |
LifeMD, Inc. operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men’s telehealth brand that provides access to virtual medical treatment for a variety of men’s health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies. It also provides LifeMD PC, a direct-to-consumer virtual primary care which includes 24/7 access to a provider for their primary care, urgent care, and chronic care needs; and offers virtual consultations and treatment, prescription medications, diagnostics and imaging, wellness coaching, and more.
LifeMD, Inc. Fundamentals Summary
LFMD fundamental statistics | |
---|---|
Market cap | US$234.73m |
Earnings (TTM) | -US$26.60m |
Revenue (TTM) | US$178.28m |
1.3x
P/S Ratio-8.8x
P/E RatioIs LFMD overvalued?
See Fair Value and valuation analysisEarnings & Revenue
LFMD income statement (TTM) | |
---|---|
Revenue | US$178.28m |
Cost of Revenue | US$19.76m |
Gross Profit | US$158.52m |
Other Expenses | US$185.12m |
Earnings | -US$26.60m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
Earnings per share (EPS) | -0.62 |
Gross Margin | 88.92% |
Net Profit Margin | -14.92% |
Debt/Equity Ratio | -880.9% |
How did LFMD perform over the long term?
See historical performance and comparison